The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE
Titel:
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE
Auteur:
Maccauro, Marco Cuomo, Mariarosaria Bauckneht, Matteo Bagnalasta, Matteo Mazzaglia, Stefania Scalorbi, Federica Argiroffi, Giovanni Kirienko, Margarita Lorenzoni, Alice Aliberti, Gianluca Pusceddu, Sara Giuseppina, Calareso Garanzini, Enrico Matteo Seregni, Ettore Chiesa, Carlo
Verschenen in:
European journal of nuclear medicine and molecular imaging